SCHEMBL6498651

SCHEMBL6498651

CN(CC(=O)OCc1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.51
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
POLB P06746 1/20 0.51
ALDH1A1 P00352 7/20 0.47
L3MBTL1 Q9Y468 4/20 0.47
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
HTT P42858 1/20 0.45
MAPK1 P28482 1/20 0.45
HPGD P15428 1/20 0.43
GAA P10253 1/20 0.43
DRD4 P21917 1/20 0.43
KDM4E B2RXH2 2/20 0.43
P2RX4 Q99571 1/20 0.42
MAOB P27338 1/20 0.41
MMP1 P03956 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6501659 0.80 LMNA (0.48) NPSR1HTTMAPK1GAA
SCHEMBL2499648 0.79 ALDH1A1 (0.49) MAPTMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL10787316 0.78 ALDH1A1 (0.47) MAPTMEN1KMT2APOLBALDH1A1
SCHEMBL557889 0.77 SMN1; SMN2 (0.55) MAPTMEN1KMT2AALDH1A1GAA
Hydrochloric Acid SCHEMBL7150239 0.75 SMN1; SMN2 (0.54) MAPTMEN1KMT2AALDH1A1GAA
SCHEMBL11001722 0.75 ALDH1A1 (0.79) MAPTMEN1KMT2APOLBALDH1A1
SCHEMBL20644643 0.75 ALDH1A1 (0.58) MAPTKMT2AALDH1A1L3MBTL1MAPK1
SCHEMBL11228033 0.75 MEN1 (0.41) MEN1KMT2AALDH1A1L3MBTL1GAA
SCHEMBL19726788 0.75 ALDH1A1 (0.61) MAPTKMT2AALDH1A1L3MBTL1CYP1A2
SCHEMBL18180860 0.75 KMT2A (0.43) MEN1KMT2APOLBALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6900244-B2 Anilino liver X-receptor modulators PHARMACIA CORPORATION (US) 2005-05-31 US disclosed
US-20040087632-A1 Controlling metabolism of lipids, cholesterol PHARMACIA CORPORATION 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087632-A1 Controlling metabolism of lipids, cholesterol NR1H2, NR1H3, SREBF1 MAPT 4053/4885MEN1 3557/4885KMT2A 2803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.